Delivery Order SPE2DB22D2005-SPE2DB23FJSR1
Award Date 8/7/23
Potential Completion Date 8/8/23
Potential Value $101
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at three hundred twenty-eight dollars and four cents ($328.04) to supply one hundred milliliters (100mL) of Omnipaque 300 mg/mL injectable contrast media to the Defense Logistics Agency Troop Support Medical (DLA). Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania between September 28 and 29, 2023. No subcontractors or set...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at one thousand four hundred eighty-nine dollars and sixty cents ($1,489.60) to supply one hundred milliliters (100mL) of Omnipaque 350 mg/mL injectable contrast media bottles to the Defense Logistics Agency Troop Support Medical (DLA) located in Conshohocken, Pennsylvania. Performance will take place at the prime contractor's corporate office division in...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $201,040 delivery order by the Defense Logistics Agency to provide 100 milliliter bottles of Omnipaque 350 MG/ML injectable contrast media. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period concluding on September 8, 2023. The firm fixed price contract was issued under the DLA's Prime Vendor program, which establishes indefinite...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $50,260 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 100mL bottles of Omnipaque 350 MG/ML injectable contrast media. Performance will take place in Conshohocken, Pennsylvania under a one-day period from July 10-11, 2023. The contract was issued utilizing the Medical-Surgical Prime Vendor program, a strategic sourcing initiative of the Defense...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $753.90 delivery order by the Defense Logistics Agency to provide 100ml bottles of Omnipaque 350 MG/ML injectable contrast media for radiological procedures. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price contract spanning September 11-12, 2023. The Defense Logistics Agency utilizes this type of medical supply to support radiology operations within the...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $34,320 firm fixed price delivery order by the Defense Logistics Agency to provide Omnipaque 300 MG/ML Pluspak 30ML contrast media. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 29th to 30th, 2023. The contract was awarded under the DLA's Prime Vendor program, which establishes indefinite delivery/indefinite quantity contracts with commercial...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,512.50 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 100ml bottles of Omnipaque 350 mg/ml infusible contrast media. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 28, 2023. No set-aside designation was applied. As a prime contractor supporting DLA Troop Support Medical programs,...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $503.84 delivery order contract by the Defense Logistics Agency to provide 4561695437 OMNIPAQUE 240 MG/ML VIAL 10ML. The contract is for a firm fixed price and will be performed in Conshohocken, Pennsylvania between August 3rd and 4th, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders under various...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $243.81 delivery order against the Defense Logistics Agency's prime vendor contract to supply Omnipaque 240 mg/ml vials. The firm fixed price order is for 20 ml vials of the contrast medium and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 8, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency utilizes...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB23FJSR1Delivery Order
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at one hundred dollars and fifty-two cents ($100.52) by the Defense Logistics Agency of the Department of Defense. The firm fixed price order is for the delivery of one hundred milliliters (100mL) of Omnipaque 350, an iodinated contrast medium used in radiology procedures, to a location in Conshohocken, Pennsylvania. Performance will take place on August 7-8, 2023 under an existing DLA contract vehicle. No subcontractors or set aside designations were indicated. This order supports the DLA's mission to provide medical supplies to the Armed Forces.
Generated 12/17/23, 8:21 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $101 | 8/7/23 |